Literature DB >> 6551179

Characterization of the effects of cultured vascular cells on the activation of blood coagulation.

G M Rodgers, C S Greenberg, M A Shuman.   

Abstract

The coagulant properties of intact bovine vascular cells (aortic endothelial and smooth muscle cells) and human vascular cells (cutaneous and foreskin microvascular cells, umbilical venous endothelium) grown in vitro were studied. Compared to nonvascular cells (fibroblasts, corneal endothelial cells, fetal lung or intestinal mucosal cells), vascular cells had little procoagulant activity. Radioimmunologic measurement of thrombin in recalcified plasma demonstrated markedly lower concentrations of thrombin in the presence of vascular endothelial and smooth muscle cells compared to corneal endothelial and fetal lung cells. The low thrombin concentrations were not a consequence of thrombin binding to the vascular cells nor were they due to accelerated thrombin inactivation by antithrombin-III or alpha 2-macroglobulin. Neither vascular cells nor the nonvascular cells promoted contact activation of plasma as measured by a sensitive specific assay for kallikrein. Studies with intact cell monolayers and purified factors VIIa and X indicated that while nonvascular cells express tissue factor activity, vascular cells do not exhibit this property. These data suggest that the nonthrombogenic nature of intact vascular cells is due to their failure to initiate contact activation and to express tissue factor activity. In addition, the primary difference in coagulant potential between vascular cells and nonvascular cells is the lack of tissue factor expression by the vascular cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6551179

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Inhibition of the activation of Hageman factor (factor XII) by human vascular endothelial cell culture supernates.

Authors:  O D Ratnoff; B Everson; P Embury; N P Ziats; J M Anderson; M M Emanuelson; C J Malemud
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells.

Authors:  T A Drake; M Pang
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

3.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors:  T A Drake; J H Morrissey; T S Edgington
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

4.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

Authors:  G M Rodgers; W H Kane
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

Review 5.  Infective endocarditis during infancy and childhood: current status.

Authors:  S K Sanyal; M A Saleh; A Abu-Melha
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

6.  Isolation and long-term serial cultivation of endothelial cells from the microvessels of the adult human dermis.

Authors:  P M Davison; K Bensch; M A Karasek
Journal:  In Vitro       Date:  1983-12

7.  Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits.

Authors:  T A Drake; G M Rodgers; M A Sande
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 8.  Thrombin generation, fibrin clot formation and hemostasis.

Authors:  Alisa S Wolberg; Robert A Campbell
Journal:  Transfus Apher Sci       Date:  2008-02-20       Impact factor: 1.764

9.  Prothrombin is activated on vascular endothelial cells by factor Xa and calcium.

Authors:  G M Rodgers; M A Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

10.  Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis.

Authors:  M J Bancsi; M H Veltrop; R M Bertina; J Thompson
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.